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Hypothalamic-Pituitary-Adrenal 
(HPA) Axis and Chronic Fatigue 
Syndrome in Older Adults: The 
Rehabilitation Perspectives
Frank Ho-Yin Lai, Maria Uscinska and Elaine Wai-hung Yan
Abstract
Chronic fatigue syndrome (CFS) is a long-term and debilitating condition 
that regards as a neurological disease. Its symptoms include profound physical 
and mental fatigue (characteristically made worse by exertion), muscle and joint 
pain, disturbed sleep, and both concentration and memory problems. CFS is a 
kind of human stress-related disorders that are characterized by alterations in 
hypothalamic-pituitary-adrenal (HPA) axis activity. Investigation of abnormal 
activity of the HPA axis in various neurological and neuropsychiatric disorders can 
date back at least 60 years, and its relation to CFS had been reported in the early 
1990s. This chapter further disseminated updated evidence for disruption of HPA 
function in CFS, with the explanation on the relationship between cytokines and 
HPA activities. Moreover, very limited literature had addressed the importance of 
rehabilitation to them . This chapter addresses this gap by sharing a pilot rehabilita-
tion outcome on a single-blinded randomized control trial with a parallel group 
experimental design in the application of activity scheduling (AS) program of occu-
pational therapy for a group of community-dwelling older adults with CFS. The 
primary objective is to study the outcome of physical functioning of individual 
participants. The second objective is to study the outcome of AS on impact of caring 
role through assessing individual caregivers’ perceived burden in care. The third 
objective is to study the time that needed in taking care; individuals’ perception 
of enjoyment and achievement in their participated activities will be evaluated. 
There was a significant effect of AS on the physical functioning of participants as 
measured by Functional Independence Measure (FIM), as the primary outcome 
measure, in experimental group, with Wilk’s λ = 0.72, F (2,57) = 18.75, p < 0.001. 
Moreover, in secondary outcome measures, there is a significant decrease in the 
impact of caring role as reflected by their perceived burden as measured by the 
Chinese Zarit Burden Interview (CZBI) in caring for experimental group, with 
Wilk’s λ = 0.72, F (2,97) = 18.75, p < 0.001. Another study set out to examine the 
effect of time on caring activities for those recruited couples in AS group. There was 
significant effect of AS on caring activities with Wilk’s λ = 0.71, F (2,97) = 12.47,  
p < 0.001. With proper coaching and regular facilitation regarding AS, activity 
participation in older adults with CFS can be greatly enhanced. Behavioral interven-
tion, such as AS, can supplement therapeutic treatment or may lead to decline in 
CFS symptoms.
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1. Introduction
There are two perspectives in developing this chapter [1–3]. The first perspective 
is to provide an up-to-date and intensive literature search in analyzing the physi-
ological, neurological, and molecular factors that lead to chronic fatigue syndrome 
(CFS). This part will provide the reader with background information on the 
importance of neuroimaging, clinical relationship between CFS and hypothalamic-
pituitary-adrenal (HPA) axis, and its physiological causes with different cytokines. 
The second perspective addresses the impact of CFS to individuals’ life role 
through the behavioral intervention by activity scheduling (AS). Its effectiveness 
was examined by a single-blinded randomized control trial with a parallel group 
experimental design.
CFS is a complex illness characterized by a broad range of physiological, cogni-
tive, neurological, and emotional symptoms [4]. The signs and symptoms of CFS 
include fatigue, loss of concentration, unexplained muscle or joint pain, headache, 
unrefreshing sleep, and extreme exhaustion [5]. It continues to evolve as a disabling 
phenomenon characterized by debilitating fatigue and consequential components 
that limit the functional ability of persons afflicted with the disease [6]. One impor-
tant theory in the cause of CFS is the deficits in the central nervous system and HPA 
in short [4, 7, 8].
1.1 Biomedical marker: neuroimaging
The proper diagnosis of CFS should come with specific biomedical markers, such 
as neuroimaging, in order to confirm with the subjective information, signs, and 
symptoms provided by the patient in order to make the proper clinical diagnosis with 
strong clinical definition of this syndrome [9]. Reported cognitive difficulties and 
complaints of headache can be scientifically reviewed by brain imaging [10]. Three 
neuroimaging approaches have been commonly used clinically. The first of these is 
the functional magnetic resonance imaging (fMRI), which allows researchers to look 
at where in the brain activation is associated with a task or an experience [11, 12]. 
The diffusion tensor imaging (DTI) enables researchers to look at the health of the 
brain’s white matter [13], and voxel-based morphometry (VBM) allows researchers to 
investigate structural changes in the brain [14, 15]. These three approaches were used 
to scientifically examine by imaging on how likely it was for the reported fatigue 
from patients. Moreover, a number of well-cited correlational studies between 
neuroimaging and clinical measurements showed the strong evidence in applying 
neuroimaging [16] and particularly for CFS [17]. There was a significant negative 
correlation between micro-structural integration, such as radial kurtosis, reflect-
ing biological microenvironment imaging metric in the hypothalamus [17, 18] and 
fatigue-related scale in traumatic patients [19].
1.2 Relationship between CFS and HPA
Symptoms of CFS include persistent fatigue, difficulty with memory and 
concentration, a disturbed sleep pattern, and severe musculoskeletal pain [20]. 
The symptoms displayed vary from individuals; some may need to remain bed 
rest for long periods of time [8], while others are able to manage their fatigue by 
maintaining their own activities of daily living [3]. CFS presents with symptoms 
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and abnormalities of HPA [21]. The HPA axis dysregulation may have a causal role 
in CFS [1, 19, 22]. Diagnosis is difficult because there is no diagnostic marker for 
the disease and no standard test; rather, a diagnosis is based on the description and 
duration of symptoms [2], degree of impairment [7], and clinical findings that 
rule out other diseases [23]. The effect on lifestyle and self-image are considerable 
because of significant changes in participation in activities, identity, and occupa-
tional issues [24].
Dysregulation of the biological systems which mediate the response to stress 
potentially has an important role in the etiopathogenesis of CFS [25, 26]. The 
neurobiological stress system comprises a range of networks that form intricate 
pathways; an important part of this is the HPA axis [27, 28] which is a self-regulated 
feedback system which contributes to the maintenance of homeostasis and which 
is impacted by multiple factors such as time of day and physical and psychological 
stressors [20]. CFS is a debilitating illness which was classified as a neurological 
disease [29]. Experimentally induced, or pathological, hypocortisolemia (as in 
Addison’s disease) is associated with symptoms typical of CFS, including fatigue, 
weakness, and abdominal pain, but it is also associated with a range of other 
features which are not typical of CFS [30]. Inactivity, sleep disturbance, psychiatric 
comorbidity, medication, and ongoing stress experienced by people with CFS will 
affect HPA axis function [1, 28, 31, 32], and the findings that HPA axis dysregula-
tion is more prominent in patients with a longer duration of illness suggest that the 
endocrine changes may be secondary [33, 34]. Researchers further supported that 
the individual variation in HPA axis regulation in patients with CFS argues for a 
heterogeneous and multifactorial bidirectional relationship between the endocrine 
disturbance and the disorder [35].
1.3 Physiological causes of CFS
Feelings of fatigue are common symptoms associated with infectious diseases 
and many other physical [36] and mental pathologic conditions [37]. Since the 
early 1990s, there has been a systematic study on changes in CFS that occur with 
infection or following microbial product-induced cytokine production in relation 
to CFS [38–40]. Moreover, research has shown a strong interaction between the 
HPA axis and the immune system [41, 42]. Some cytokines have stimulating effect 
on the HPA axis, whereas cortisol, the end product of the HPA axis, suppresses 
secretion. Elevated tumor necrosis factor α (TNFα), interleukin-2 (IL-2), and/or 
interleukin-6 (IL-6) levels may be the mediators of fatigue associated with primary 
or secondary adrenal insufficiency.
1.4 Tumor necrosis factor α
TNFα is an inflammatory cytokine that is predominantly produced by activated 
macrophages. In addition, TNFα is also expressed by other immune cells (lymphoid 
cells, mast cells, fibroblasts) as well as endothelial cells and nerve cells. TNFα is 
a key signaling molecule for cell death process (by activation of NF-κB and JNK-
MAPK pathways). Therefore, TNFα may indicate pathological mechanisms of 
numerous diseases, including neural degeneration common to neurocognitive disor-
ders. Indeed, TNFα has been associated with Alzheimer’s disease and mild cognitive 
impairments. Increased levels of TNFα have been found in serum and CSF [43], as 
well as postmortem brain tissues [44] of Alzheimer’s disease patients compared with 
control subjects. Moreover, the elevation in TNF was apparent before the emergence 
of overt cognitive deficits [44]. Its potential as an early marker therefore certainly 
warrants investigation, especially from a longitudinal perspective. TNFα secretion 
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in young adults showed a statistically significant circadian rhythm with a peak close 
to the offset of sleep [45]; such a rhythm was not present in older adults [46].
1.5 Interleukin-6
IL-6 is a pleiotropic cytokine released by a host of immune cells (T cells and 
monocytes) [47], and it plays a critical role in the regulation of the inflammatory 
responses in the host immune defense. Specifically, IL-6 stimulates B-cell differen-
tiation and antibody production. Higher levels of IL-6 are associated with various 
autoimmune and inflammatory diseases. The risk of a decline in Mini-Mental State 
Examination (MMSE) over a 10-year period is higher among people with higher 
IL-6 levels (odds ratio = 1.81, CI95%, 1.20, 2.71) [48]. The same study also showed 
that IL-6 levels predicted the magnitude of 10-year decline in reasoning (high IL-6, 
20.35; CI95%, 20.37, 20.33 vs. low IL-6, 20.29; CI95%, 20.31, 20.27). Through syner-
gistic interaction with other cytokines, IL-6 also regulates platelet production by 
bone marrow cells (via synergy with IL-3-regulated megakaryocyte development), 
secretion of acute-phase proteins by liver cells (via synergy with IL-1), and bone 
homeostasis (e.g., via RANKL-mediated mechanism) [48].
IL-6 in humans caused profound somnolence and fatigue [49]. Literature 
reviewed the decrease in overall secretion of IL-6 is associated with a good sleep 
that is associated with decreased exposure of tissues to the proinflammatory [50] 
and potentially detrimental actions of IL-6 on the cardiovascular system, insulin 
sensitivity, and bones [51–53].
1.6 Adrenal insufficiency
Adrenal insufficiency is associated also with chronic fatigue [4, 54]. Previous 
studies indicated that untreated patients with adrenal insufficiency demonstrated 
increased sleep fragmentation [55, 56], findings that may explain the patients’ 
fatigue. These sleep abnormalities were reversed following treatment with a 
replacement dose of hydrocortisone. These results suggest that cortisol secretion 
may be needed to facilitate both initiation and maintenance of REM sleep. It should 
be noted that in normal individuals, exogenous glucocorticoids have been found to 
reduce REM sleep [57]. Behaviorally, excessive daytime sleepiness is prominent in 
patients with secondary adrenal insufficiency [58].
1.7 Impact of CFS to individuals’ life roles
Fatigue, a poorly defined phenomenon and subjective in nature, was described 
by CFS sufferers as continuous, resulting in diminished engagement in activities 
[59]. It was found that most individuals with CFS actually underreported their 
disabilities [6]. Moreover, functional limitations consequently affect the successful 
completion of tasks and roles [3]. The loss or diminishment of these roles as provid-
ers, family members, and peers affects not only functional relationships but also the 
quality of life of their partners, family members, and significant others [60, 61].
1.8 Intervention
Because the etiology of CFS is unidentified, the relief of symptoms is the 
primary goal when treating this population. Previously, the effectiveness of many 
of the treatments was unproven (Berne, 2002). Nowadays, apart from pharma-
cological interventions [62, 63], some directions were shown to be effective, 
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like nutrition [64] and use of exercise [65–68] and cognitive behavioral therapy 
[69, 70]. The general consensus was that graded exercise therapy (GET), cognitive 
behavioral therapy (CBT), and “pacing” (energy conservation) showed the most 
positive results.
1.9 Consideration of rehabilitation for CFS
Literature has shown behavioral intervention can supplement therapeutic treat-
ment [71] or may lead to decline in CFS symptoms [72, 73]. Occupational therapy 
addresses problems for those individuals at risk or already experiencing problems 
in performing activities that affect functional independence, health, and wellbeing 
due to accident, illness, or delays [3]. As a holistic practice, occupational therapy 
addresses individuals’ physical, social, and psychological areas of life. Much has 
been contributed by occupational therapists to populations with chronic disease 
and populations with fatigue, loss of concentration, unexplained musculoskeletal 
pain, and amotivational symptoms that are similar to CFS [6]. The focus of occupa-
tional therapy is placed on individuals’ meaningful participation of activities [74]. 
This may act as structuring the engagement in activities of older adults need to do 
(self-care), enjoy doing (leisure), and do for progress (productivity) and help them 
to develop a sense of self-worth and wellbeing [75–78].
Activity scheduling is a tailor-made personalized activity that can be used as 
a media for behavioral activation [79, 80]. AS is the technique that compromise 
the advantages of GET, CBT, and energy conservation techniques. It has been 
established as a core component of evidence-based treatment for depression with 
equivalent outcomes to cognitive behavioral therapy [81], through introduc-
ing small and easily achievable changes, gradually building up levels of activity 
toward individualized short-term to long-term goals [80]. In their meta-analysis 
on randomized effect studies of AS, 16 studies with 780 subjects were included. 
The pooled effect size indicating the difference between AS intervention and 
control conditions yield a large effect size of 0.87 (95% CI, 0.60–1.15). Moreover, 
there was a robust association between AS during treatment and self-reported 
activity engagement as well as clinically significant improvements in depression 
[82, 83]. AS is an effective behavioral intervention that can address social isolation 
in older adults [83, 84]. Older adults can experience higher degrees of engagement 
in social activities, more chances to experience positive emotions [83], and a sense 
of not being negatively affected or neglected in their limited interactions with 
their environments [85]. Moreover, AS has been shown to be effective in enhanc-
ing individuals’ quality of life through increasing their active participation in 
activities [80, 82].
This study is a pioneer attempt to examine if AS would show its effectiveness in 
the management of older adults whom suffered from CFS. The primary objective is 
to study the outcome of physical functioning of individual participants. The second 
objective is to study the outcome on impact of caring role through assessing individ-
ual caregivers’ perceived burden in care. The third objective is to study the time that 
needed in taking care and individuals’ perception of enjoyment and achievement in 
their participated activities.
2. Methods
This 10-week longitudinal study was a single-blinded randomized control trial 
with a parallel group experimental design.
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2.1 Participants
Older adults with CFS and their spouse caregivers would be recruited. Both of 
them should be age-ranged from 65 to 70 years. Participants with CFS should have 
a diagnosis in their medical history under the ICD-10 criteria which was diagnosed 
by a physician. Individuals’ cognitive function would be screened by the Montreal 
Cognitive Assessment Hong Kong Version (MoCA-HK) [86]. To ensure participants 
having intact cognitive function, both participants with CFS and their spouse 
caregivers would be screened with MoCA-HK and should have a score >26. After 
provision of clear verbal and written explanation on the purpose of this study, they 
will provide their consent with the presence of their social workers. Approval was 
given by the local research ethics committee, and the study was conducted according 
to the Declaration of Helsinki.
2.2 Interventions
Participants with CFS and their spouse caregivers in both groups received a health 
education program with weekly themed topics, such as the importance of exercise 
and healthy eating, sleep management, counseling, acceptance therapy, and commit-
ment therapy in the first and second weeks. For the following 8 weeks, they would be 
randomized and received one of the two interventions. Healthcare Education group, 
as control group, would receive eight weekly education sessions on health and physical 
care education offered by lecturers of occupational therapy from a local university. 
In experimental arm, Healthcare Education-Activity Scheduling (Healthcare ED-AS 
group) would receive the same health and physical care education program and AS 
training, focusing on pleasant activities and improving communication.
After receiving three-session training from two occupational therapists, AS 
became a caregiver-delivered intervention, and it involves five steps: (1) baseline 
assessment, (2) discussion, (3) homework, (4) enhancing motivation and encour-
agement, and (5) reassessment. Moreover, those two occupational therapists who 
conducted the training would provide weekly telephone follow-up for caregivers as 
the strategy in encouraging individuals’ completion of program.
In the baseline assessment, researcher interviewed each couple in their own 
home. The occupational therapist would document the activities pattern of older 
adults over the course of a week. For each activity, participants should rate their 
own sense of enjoyment (E) and achievement (A) between 0 and 10 (“0” = no sense 
of enjoyment or achievement and “10” = you enjoyed the activity very much or felt 
a strong sense of achievement). Participants would mark this immediately after 
completing the activity or at the end of the day. Moreover, measures on the amount 
of time in taking care and individuals’ perception of enjoyment and achievement 
in their participated activities would serve as the baseline reading of their current 
activity levels. In discussion, activities chosen in AS had to be related on what the 
participants had been avoiding and help them to act in accordance with their valued 
directions. Spouse caregivers were asked to monitor the mood when they partici-
pated in their scheduled activities. They would be evaluated whether or not what 
they did was in keeping with their goals and valued directions. They were encour-
aged to make notes, and the occupational therapist would provide regular support 
in regard to assessing areas that were still avoided and activities that are overused. 
In homework, spouse caregivers could use the activity achievement worksheet to 
indicate how they spent their time, as well as how the activities affected their mood. 
In enhancing motivation and encouragement, individuals’ adherence and compli-
ance to AS would be documented through this homework in reflecting their level of 
participation. Strategies on regular telephone follow-ups would be used to enhance 
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individuals’ motivation to complete the 8-week intervention. Depending on the 
couple’s progress, changing or adding activities might be appropriate. In reassess-
ment, the set of measurements as in the baseline measures would be reassessed.
2.3 Outcomes/instrument
The primary objective is to study the outcome of physical functioning of indi-
vidual participants. The second objective is to study the outcome of AS on impact of 
caring role through assessing individual caregivers’ perceived burden in care. The 
third objective is to study the time that needed in taking care; individuals’ percep-
tion of enjoyment and achievement in their participated activities will be evaluated.
The primary outcome on impact of physical functioning is measured by the 
Functional Independence Measure (FIM). It is an 18-item measurement tool that 
explores an individual’s physical, psychological, and social function [87]. The tool 
is used to assess a patient’s level of disability as well as change in patient status in 
response to rehabilitation [88, 89] or medical intervention [90]. FIM is comprised 
of 18 items, grouped into 2 subscales—motor and cognition. The motor subscale 
includes eating, grooming, bathing, dressing upper body; dressing lower body, 
toileting, bladder management, and bowel management; transfers, bed/ chair/
wheelchair; transfers, toilet; transfers, bath/shower; walk/wheelchair; and stairs. 
The cognition subscale includes comprehension, expression, social interaction, 
problem-solving, and memory. Each item is scored on a 7-point ordinal scale, 
ranging from a score of 1 to a score of 7. Score 1 is total assistance with helper, 2 is 
maximal assistance with helper, 3 is moderate assistance with helper, 4 is minimal 
assistance with helper, 5 is supervision or setup with helper, 6 is modified indepen-
dence with no helper, and 7 is complete independence with no helper. The higher 
the score, the more independent the patient is in performing the task associated 
with that item. The total score for the FIM motor subscale (the sum of the indi-
vidual motor subscale items) will be a value between 13 and 91. The total score for 
the FIM cognition subscale (the sum of the individual cognition subscale items) 
will be a value between 5 and 35. The total score for the FIM instrument (the sum of 
the motor and cognition subscale scores) will be a value between 18 and 126.
The secondary outcome is to study the caregiving burden. The 22-item Chinese 
Zarit Burden Interview (CZBI) [91, 92] would be used to measure individuals’ care 
burden. Scores range from 0 to 88 and higher scores indicate higher levels of burden.
The third outcome will be individuals’ record of time, and activities; their per-
ception of enjoyment and achievement will be recorded in the activity achievement 
worksheet (Figure 1) by the family caregivers. The activity achievement worksheet 
helps caregivers to plan activities for the week ahead that give opportunities for 
Figure 1. 
Activity achievement worksheet.
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social interaction, enjoyment, and social interaction with others. To ensure the 
measure of fidelity of the AS program, both experimental and control group will 
log their activities. With the presence of blinded assessor, these outcome measures 
would be administrated in baseline and after the 8-week program.
3. Results
From August 2014 to August 2018, a total of 64 community-dwelling couples, 
composed of older adults with CFS and their spouse caregivers, were recruited from 
two local day activity centers for older adults. Four participants failed to complete 
the consent due to language barrier. Of these couples, 30 were randomly assigned to 
control group and 30 were randomly allocated to experimental AS group. Two pairs 
of couples in control group defaulted their follow-up after the first week program. 
In the experimental group, one pair of couples defaulted follow-up and another one 
family caregiver passed away within the first two sessions of the study. Therefore, 
56 pairs of couples were resulted as shown in Figure 2.
3.1 Baseline data
The 28 pairs of couples in the Healthcare Education group comprised 14 males 
and 14 females with ages ranging from 66 to 82 years (mean age = 69.25, SD = 16.32) 
and educational levels from 3 to 13 years (mean = 7.82, SD = 4.29). Moreover, the 28 
Figure 2. 
Participant flow in CONSORT diagram.
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participants in the Healthcare Education-Activity Scheduling (Healthcare ED-AS 
group) were composed of 17 males and 11 females, with ages ranging from 67 to 
84 years (mean age = 70.23, SD = 12.34) and educational levels from 3.5 to 13.2 years 
(mean = 7.52, SD = 5.23). All recruited participants were home living. There were 
no significant differences between the two groups regarding age, years of educa-
tion, or cognitive ability at baseline, as determined by the MoCA score (as shown in 
Table 1), and outcome measures among these groups are depicted in Table 2.
There were no significant differences in the baseline measurements taken for 
primary outcome measure on individuals’ physical functioning as measured by 
FIM (with Cohen’s d ranged from 0.02 to 0.08, p > 0.05). Moreover, there were no 
significant differences in individuals’ impact of caring role (with Cohen’s d ranged 
from 0.02 to 0.08, p > 0.05) and no significant difference in the amount of time 
spent taking care of relatives with CFS (with Cohen’s d ranged from 0.03 to 0.06, 
p > 0.05).
After 8-week intervention, there were some changes in different outcome 
measures. For the primary outcome measure on individuals’ physical functioning, 
paired t-test revealed a significant improvement in motor-FIM score in experimen-
tal group (with t (59) = −0.38, p < 0.05, with Cohen’s d ranging from 0.30 to 0.44, 
95% CI, 0.25 to 0.78), but not in control groups (p > 05).
In secondary outcome measure on the impact of caring role that was assessed 
using the CZBI, paired t-test revealed a significant improvement in uncertainty, 
subjective feeling, negative emotion, dependency, feelings of inadequacy, and total 
burden of care in experimental group (with t (59) = −0.38, p < 0.05, with Cohen’s 
d ranging from 0.30 to 0.44, 95% CI, 0.25 to 0.78), but not in control groups 
(p > 0.05).
In the third outcome measure on caring activities, there was a significant 
decrease in reported caring activities on communication, use of transport,  dressing, 
eating, and looking for appearance with Cohen’s d ranging from 0.23 to 0.53. 
Healthcare Education group
(n = 28)
Healthcare Education-Activity 
Scheduling (Healthcare ED-AS 
group)
(n = 28)
Gender
Older adult with CFS Male: 14
Female: 14
Male: 17
Female: 11
Spouse caregivers Male: 14
Female: 14
Male: 11
Female: 17
Age
Older adult with CFS 69.25 ± 5.32 70.23 ± 5.32
Spouse caregivers 71.23 ± 4.68 71.49 ± 3.73
Education level of caregivers From 3 to 13 years 
(mean = 7.82 ± 2.18)
From 3.5 to 11 years 
(mean = 7.79 ± 2.06)
Cognitive function 
(Montreal Cognitive 
Assessment-HK version)
Older adults with CFS 18.16 ± 0.64 18.06 ± 0.52
Spouse caregivers 27.16 ± 0.58 28.06 ± 0.39
Table 1. 
Baseline demographics and clinical characteristics for each group.
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Moreover, there is a significant decrease in reported caring hour from 6.98 to 
5.98 hours (with t (59) = −0.89, p < 0.05, Cohen’s d = 0.53 with 95% CI, 0.51 to 
0.68) in the experimental AS group and no significant difference in caring hours in 
control group from 7.02 to 7.42 hours.
In the measurement of spouse caregivers’ subjective perception of enjoyment 
and achievement in activities they were instructed to complete an achievement 
worksheet. After 8-week intervention, the experimental group outperformed the 
control group in their number of activity participation (Cohen’s d = 0.90 with 95% 
CI = 0.68–0.95), level of enjoyment (Cohen’s d = 0.74 with 95% CI = 0.65–0.82), 
and sense of achievement (Cohen’s d = 0.55 with 95% CI = 0.49–0.71). Moreover, 
in experimental group, participants reported with more physical exercise (ranging 
Healthcare 
Education 
group
(n = 28)
Healthcare 
Education-
Activity 
Scheduling 
(Healthcare 
ED-AS group) 
(n = 28)
Healthcare 
Education group
(n = 28)
Healthcare 
Education-
Activity 
Scheduling 
(Healthcare 
ED-AS group)
(n = 28)
Before intervention After 8-week intervention
Primary outcome measure
Functional 
Independence 
Measure
Motor-FIM 48.07 ± 1.35 48.23 ± 1.37 51.97 ± 1.57 77.47 ± 1.71
Cognitive-FIM 18.07 ± 1.36 18.19± 1.31 21.87 ± 1.82 26.53 ± 1.68
Total-FIM 66.13 ± 4.56 67.25 ± 4.35 83.96 ± 2.82 102.63 ± 1.71
Secondary outcome measure
Caregiver 
burden
Uncertainty 8.07 ± 1.36 8.13 ± 1.31 7.97 ± 1.47 7.47 ± 1.71
Subjective 
feeling
22.80 ± 1.86 22.73 ± 1.74 22.70 ± 2.51 23.66 ± 2.45
Negative 
emotion
11.87 ± 2.22 11.70 ± 2.13 11.72 ± 3.70 10.37 ± 2.11
Dependency 9.47 ± 1.31 9.33 ± 1.30 9.48 ± 1.22 9.10 ± 1.30
Feeling of 
inadequacy
5.37 ± 1.40 5.40 ± 1.40 5.23 ± 1.34 4.70 ± 1.34
Total 57.56 ± 4.25 57.43 ± 4.05 57.21 ± 3.76 54.70 ± 4.46
Secondary outcome measure
Activity 
achievement 
worksheet
Number of 
activities
11.23 ± 2.61 11.26 ± 2.32 10.84 ± 2.87 12.24 ± 1.32
Enjoyment 4.65 ± 1.79 4.71 ± 1.89 4.67 ± 1.81 6.22 ± 2.19
Achievement 4.32 ± 1.79 4.45 ± 1.85 4.26 ± 1.97 5.32 ± 1.87
Table 2. 
Outcome measures for each group.
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from physical exercise to more leisurely exercise, such as walking, gardening, yoga, 
or hiking) in their later reported figures from week 5 onward than less active physi-
cal activities (including shopping, baking, attending community events, arts and 
crafts, singing, and tea or lunch with friends or family) as in their earlier reported 
activities. Moreover, gradually increasing levels of social interaction with others 
were noted in experimental group than in control group. On the contrary, control 
group showed some more passive activities (such as reading a newspaper, watch-
ing TV, listening to the radio, looking at photo albums, and writing in a journal) 
throughout the period of 8-week intervention.
3.2 Within-group difference
After 8-week intervention, there were significant differences in some measures 
within experimental group but not in control group. For the primary outcome 
measure on individuals’ physical functioning, paired t-test revealed a significant 
improvement in motor-FIM and total-FIM (with t (27) = 11.45, p < 0.05, with 
Cohen’s d ranging from 0.68 to 1.64, 95% CI, 0.38 to 1.78), but not in control groups 
(p > 0.05). The secondary outcome measures on the impact of caring role. Paired 
t-test revealed a significant improvement in uncertainty, subjective feeling, negative 
emotion, feelings of inadequacy, and total burden of care in experimental group 
(with t (27) = −0.45, p < 0.05, with Cohen’s d ranging from 0.43 to 0.64, 95% CI, 
0.38 to 0.78), but not in control groups (p > 0.05).
There was significant difference in spouse caregivers’ own subjective percep-
tion of enjoyment and achievement in activities within experimental group but not 
in control group. Following 8-week intervention, within the experimental group 
yielded the following results:  the number of activity participation (Cohen’s d = 
0.52 with 95% CI = 0.48–0.65), level of enjoyment (Cohen’s d = 0.74, 95% CI = 
0.65–0.81), and sense of achievement (Cohen’s d = 0.46 with 95% CI = 0.43–0.62).
3.3 Examine the improvement over time in intervention group
A two-group pretest-posttest ANOVA with repeated measures was conducted 
to compare the effect of time before and after the 8-week intervention. There was 
a significant effect of AS on the physical functioning of participants with CFS in 
experimental group, with Wilk’s λ = 0.72, F (2,57) = 18.75, p < 0.001. Moreover, 
there was a significant decrease in the impact of caring role as reflected by the 
perceived burden of caring in the experimental group, with Wilk’s λ = 0.72, F (2,97) 
= 18.75, p < 0.001. Furthermore, a study of the effect of time on caring activities 
for those recruited couples in AS group revealed a significant effect of AS on caring 
activities with Wilk’s λ = 0.71, F (2,97) = 12.47, p < 0.001.
4. Discussion
The present study revealed that there was a positive effect of AS on improve-
ments in activity participation in older adults with CFS. This finding echoes 
previous work on AS in regard to depression in older adults [82, 83]. Through 
this study, it became obvious that there were more activities that older adults 
with CFS and their spouse caregivers would like to and could participate than we 
expected. AS showed its advantages with the GET, CBT, and energy conservation 
techniques. This is very important topic as non-pharmacological interventions 
are needed for this hard to treat population. With the application of AS in experi-
mental group, there was more significant improvement regarding individuals’ 
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physical functioning, as our primary outcome measure, in the experimental group. 
Moreover, there will be lighter perceived impact of caring role and significant 
reductions in uncertainty, dependency, and the feeling that caregivers were provid-
ing inadequate care. These positive changes can be partially explained by having 
proper channel in having more regular feedback and sharing on their caring with 
occupational therapists in the AS program. This channel had shown to be a strong 
form of support to caregivers in regard to caregiving [83, 93].
Moreover, in experimental group, AS training offered by occupational therapists 
focused on pleasant event scheduling and improving individuals’ communication. 
Results indicated individuals’ feelings of uncertainty and inadequacy can be greatly 
alleviated if they participate in activities together with the people for whom they care. 
The present findings echoed the effectiveness of this type of activity participation, 
and support had been well documented that can lower the impact of caring role in 
their daily lives [84, 94]. It is very important to note that not only CFS but also depres-
sion would affect people differently when it comes to their daily activities [95, 96]. It 
had been found that fatigue and depression had mutual interactions [97] and there 
can be some overlap between the two [98]. AS training showed its effectiveness in 
behavioral intervention for CFS. The application of AS and findings of this study can 
be applied to other common neuropsychological metrics such as in depression and for 
others with mild cognitive impairment. There were some studies that had documented 
its effectiveness in depression [80].
One of the most attractive assets of AS was its relatively straightforward and 
personalized metric in nature. With not much preparation and resources needed, it 
makes easy for different healthcare providers to adopt this approach in motivating 
our patients and their caregivers to have more activity participation. This easy-
operation intervention can bring benefits to various sociodemographic levels of our 
society.
This study provided insights on the importance of biopsychosocial approach in 
the evaluation and management for CFS. Moreover, in rehabilitation, it is funda-
mentally important to let the participants choose activities by themselves, in order 
to enhance their levels of participation in the activities [99]. There were gradually 
increases of enjoyment and achievement and levels of social interaction noted in 
their reported activity achievement worksheet. It is reasonable to believe that with 
proper coaching and regular facilitation regarding AS by occupational therapists, 
activity participation in older adults with CFS can be greatly enhanced, just as it 
can be for other older adult populations [82, 100, 101]. This study further echoed 
previous well-cited studies in indicating behavioral intervention can supplement 
therapeutic treatment or may lead to decline in CFS symptoms [71–73, 102].
The present study relied on self-report and completion of daily activity logs in 
reflecting individuals’ activity participation. This will limit the power of this study 
as social desirability bias and forgotten to complete the report would jeopardize the 
outcome of AS. A more standardized environment would much enhance the effi-
ciency in building events for AS.  Also, a well-cited experimental research in using 
neuroimaging to probe mechanisms of behavior change is needed [103]. Further 
resources should be solicited in making a correlation analyses with neuroimaging 
on justifying the effectiveness of this behavioral intervention.
Up till present, there was limited literature in showing the effectiveness of 
rehabilitation service for older adults with CFS. The effectiveness of AS can be 
further justified by conducting a study with larger group of participants and with 
longer-term follow-up. Regular telephone follow-ups had shown to be an effective 
method to maintain satisfactory compliance and adherence of caregivers; therefore, 
more resources should be prepared to work up closer on compliance and adherence 
of individuals’ participation in activity and their scheduling.
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